ArQule Message Board - Msg: 1123860

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ArQule

ARQL 20.00

0.0%

Jan 16 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (56)	4/4/1997 8:30:00 AM
From: Dr. John M. de Castro	of 399

The fundamentals of ARQL have nothing to do with the recent trashing of the stock value. I completely agree with Rick, This is still a great company with cutting edge technology, excellent management, strong financing, excellent business plan, solid partnerships, a modest market cap, and a glowing future. I expect noting but good news of more deals comming out in the not to distant future. However, I wouldn't at all be surprised to see them pull back the secondary at the current levels. They're doing a road show currently to support the secondary. But, I'd be surprised if they would go ahead with it at $13-$14 per share. All they have to do is wait a few months for the stock to go back over $20 and roll it out then. They have plenty of cash, so there is no need to rush. John de C

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next